Hodgkin's disease following solid organ transplantation

P. J. Bierman, J. M. Vose, A. N. Langnas, R. M. Rifkin, R. J. Hauke, B. N. Smir, T. C. Greiner

Research output: Contribution to journalArticlepeer-review

43 Scopus citations


Background: The incidence of second malignancies is markedly increased following transplantation of solid organs. However, the development of Hodgkin's disease has been described relatively infrequently in this setting, and there is little clinical information on these patients and few details on management. Patients and methods: We have reviewed the pathologic specimens and clinical history of four patients who developed Hodgkin's disease following transplantation of solid organs. Results: Hodgkin's disease appeared 26-68 months following transplantation of the kidney (2 cases), liver, and heart. Three cases demonstrated evidence of Epstein-Barr virus (EBV) in Reed-Sternberg cells. One case appears to have arisen after a previous EBV-driven polymorphous lymphoproliferation. Hodgkin's disease was localized in three cases and disseminated in one. All patients achieved remission with standard therapy and continue in remission between 9 and 61 months after therapy. Graft function was preserved in all patients. Conclusion: Hodgkin's disease occurring in the post-transplantation period should probably be treated like Hodgkin's disease in non-immunosuppressed patients. Prolonged disease-free survival is possible and function of the transplanted organ can be preserved.

Original languageEnglish (US)
Pages (from-to)265-270
Number of pages6
JournalAnnals of Oncology
Issue number3
StatePublished - Mar 1996


  • Epstein-Barr virus
  • Hodgkin's disease
  • Organ transplantation

ASJC Scopus subject areas

  • Hematology
  • Oncology

Fingerprint Dive into the research topics of 'Hodgkin's disease following solid organ transplantation'. Together they form a unique fingerprint.

Cite this